Dianthus Grants 60,000 Stock Options to New Employees at $89.45

Dianthus Therapeutics granted non-qualified stock options for an aggregate of 60,000 shares of its common stock to three newly-hired, non-executive employees on June 1, 2026. These inducement grants, approved by the Company's independent Compensation Committee, have a 10-year term and an exercise price of $89.45 per share. The options will vest 25% on the first anniversary of the vesting commencement date, with the remainder vesting in equal monthly installments over the subsequent 36 months.